Welcome : Guest

NanoViricides, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about NanoViricides, Inc., which is principally involved in Developing Nanomedicine Technologies. Illustrated with 15 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-18895
Price: $750
Company Type: Public
Pages: 17
Date: February 2016
Market Data Tables: 15

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Antiviral Drugs......2
Table 1: Antiviral Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Antiviral Drugs, Monoclonal Antibodies, Vaccines and Others......2
Table 2: Hepatitis C Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Immuno Modulator, Polymerase Inhibitor, Protease Inhibitors, and Others (Includes Ribavirin)......3
Table 3: Hepatitis C Virus Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Immuno-Modulator, Polymerase Inhibitor, Protease Inhibitors, Ribavirin, and Others......4
Table 4: Hepatitis C Virus Market by Patient Conditions in Europe (2015) – Percentage Share Breakdown by Value for Diagnosed, Prevalence, Under Care and Others......5
Table 5: Hepatitis C Virus Market by Patient Conditions in the US (2015) – Percentage Share Breakdown by Value for Diagnosed, Prevalence, Under Care and Others......6
Table 6: Infectious Disease Drugs Market by Category Worldwide (2014) – Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......7
Table 7: No. of Hepatitis C Virus (HCV) Patients by Category in European Union (EU) (2014) - Percentage Market Share Breakdown for GT1, and Non-GT1......8
Table 8: No. of Hepatitis C Virus (HCV) Patients by Category in the US (2014) - Percentage Market Share Breakdown for GT1 HCV, GT2/3 HCV, and Others......9
Table 9: No. of Hepatitis C Virus (HCV) Patients by Category in the US (2014) - Percentage Market Share Breakdown for GT1, and Non-GT1......10
Table 10: Therapeutic Classes Market by Segment in the US (2014) – Percentage Market Share Breakdown by Value Sales for Antidiabetics, Antihypertensives, Autoimmune Diseases, HIV Antivirals, Lipid Regulators, Mental Health, Oncologics, Pain, Respiratory Agents, and Others......11
Antiviral Drugs......12
Table 11: Market Shares of Leading Anti-viral Oral Liquids Producers in China (2015) - Percentage Share Breakdown by Value for Livzon Pharmaceutical Group Inc., Xiangxue Pharmaceutical Co., Ltd. and Others......12
Table 12: Market Shares of Leading Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Co (BMY), GlaxoSmithKline Plc (GSK), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Vertex Pharmaceuticals, Inc. (VRTX), and Others......13
Table 13: Market Shares of Leading Human Papillomavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Cervarix), and Others......14
Table 14: Market Shares of Leading Human Rotavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Rotarix), and Others......15
Table 15: Nanoviricides, Inc.’s Sales by Product Segment Worldwide (2013) in Percentage for All Influenzas: FluCide, EKC-Cide™, other Eye Viral Infections, HIV-Cide, Herpes infections, Dengue, Others (Ebola, and other projects) and Unallocated Stock Compensation......16